VolitionRx Limited issued a total of 4,778,728 shares of common stock to Lind Global Asset Management XII LLC between August 27 and August 31, 2026. These issuances satisfied conversion obligations totaling $1,715,000 under senior secured convertible promissory notes originally issued in May 2025. The transactions were conducted pursuant to a securities purchase agreement and relied on exemptions from registration under Section 4(a)(2) of the Securities Act or Regulation D. VolitionRx Limited operates in the healthcare diagnostics industry, developing molecular diagnostic tests for cancer detection.
